Dana E. Vanderwall

3.0k total citations · 1 hit paper
28 papers, 2.2k citations indexed

About

Dana E. Vanderwall is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Dana E. Vanderwall has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Dana E. Vanderwall's work include DNA and Nucleic Acid Chemistry (7 papers), Metal complexes synthesis and properties (6 papers) and Scientific Computing and Data Management (4 papers). Dana E. Vanderwall is often cited by papers focused on DNA and Nucleic Acid Chemistry (7 papers), Metal complexes synthesis and properties (6 papers) and Scientific Computing and Data Management (4 papers). Dana E. Vanderwall collaborates with scholars based in United States, United Kingdom and Spain. Dana E. Vanderwall's co-authors include John W. Kozarich, JoAnne Stubbe, Wei Wu, Darren V. S. Green, Vinod Kumar, Jaume Vidal, James R. Brown, Cristina de Cózar, José Garcia-Bustos and Emilio Fernández Álvarez and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Dana E. Vanderwall

26 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thousands of chemical starting points for antimalarial lead identification

2010 705 citations Francisco‐Javier Gamo, Laura M. Sanz et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dana E. Vanderwall United States	20	1.3k	599	459	399	367	28	2.2k
Daniel Bur Switzerland	32	1.5k 1.1×	1.0k 1.7×	389 0.8×	308 0.8×	462 1.3×	88	2.9k
Silvana Grasso Italy	33	1.2k 0.9×	1.7k 2.8×	378 0.8×	324 0.8×	161 0.4×	136	3.3k
Maria Paola Costi Italy	31	1.7k 1.3×	850 1.4×	385 0.8×	499 1.3×	270 0.7×	171	3.3k
Andreas Larsson Sweden	21	1.9k 1.5×	473 0.8×	150 0.3×	397 1.0×	312 0.9×	55	2.9k
Kelly Chibale South Africa	31	815 0.6×	1.5k 2.4×	610 1.3×	447 1.1×	391 1.1×	99	2.7k
Mohammad Imran Siddiqi India	33	1.3k 1.0×	1.0k 1.7×	655 1.4×	260 0.7×	540 1.5×	186	3.1k
Martin Schlitzer Germany	23	925 0.7×	774 1.3×	763 1.7×	130 0.3×	364 1.0×	119	2.1k
Ruth Brenk United Kingdom	27	1.5k 1.2×	754 1.3×	250 0.5×	120 0.3×	659 1.8×	61	2.3k
Emilio Fernández Álvarez Spain	25	1.2k 0.9×	173 0.3×	466 1.0×	113 0.3×	278 0.8×	53	2.1k
Bart L. Staker United States	25	2.9k 2.3×	694 1.2×	147 0.3×	649 1.6×	281 0.8×	99	3.9k

Countries citing papers authored by Dana E. Vanderwall

Since Specialization

Citations

This map shows the geographic impact of Dana E. Vanderwall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana E. Vanderwall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana E. Vanderwall more than expected).

Fields of papers citing papers by Dana E. Vanderwall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana E. Vanderwall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana E. Vanderwall. The network helps show where Dana E. Vanderwall may publish in the future.

Co-authorship network of co-authors of Dana E. Vanderwall

This figure shows the co-authorship network connecting the top 25 collaborators of Dana E. Vanderwall. A scholar is included among the top collaborators of Dana E. Vanderwall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana E. Vanderwall. Dana E. Vanderwall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vanderwall, Dana E., et al.. (2024). Digit al Standards: A Path to Sustainable and Interoperable Chemical Data Exchange. Chemistry International. 46(3). 43–47.

Balakrishnan, Rama, Ellen L. Berg, Christopher Butler, et al.. (2024). Bioassay protocol metadata annotation: Proposed standards adoption. SLAS DISCOVERY. 29(8). 100188–100188.

Vanderwall, Dana E., et al.. (2021). Coming of age of Allotrope: Proceedings from the Fall 2020 Allotrope Connect. Drug Discovery Today. 26(8). 1922–1928. 13 indexed citations

Corte, Dennis Della, et al.. (2021). Self-reporting data assets and their representation in the pharmaceutical industry. Drug Discovery Today. 27(1). 207–214. 2 indexed citations

Li, Zhuyin, Youping Xiao, Darren Locke, et al.. (2020). Quantifying drug tissue biodistribution by integrating high content screening with deep-learning analysis. Scientific Reports. 10(1). 14408–14408. 2 indexed citations

Vanderwall, Dana E., Nancy Yuen, James M. Bailey, et al.. (2011). Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery – the GSK experience. Drug Discovery Today. 16(15-16). 646–653. 8 indexed citations

Coimbra, Roney S., Dana E. Vanderwall, & Guilherme Oliveira. (2010). Disclosing ambiguous gene aliases by automatic literature profiling. BMC Genomics. 11(S5). S3–S3. 3 indexed citations

Gamo, Francisco‐Javier, Laura M. Sanz, Jaume Vidal, et al.. (2010). Thousands of chemical starting points for antimalarial lead identification. Nature. 465(7296). 305–310. 705 indexed citations breakdown →

Murray, David, Eric N. Johnson, Ping Wang, et al.. (2009). Functional antagonism of IL-1α induced gene expression profiles define the cAMP/PKA pathway as a unique regulator of IL-1α signaling networks. Journal of Receptors and Signal Transduction. 29(5). 246–256. 1 indexed citations

10.

Rheault, Tara, Thomas R. Caferro, Scott H. Dickerson, et al.. (2008). Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(3). 817–820. 72 indexed citations

11.

Qiu, Yang, Dilip Rajagopalan, Susan C. Connor, et al.. (2008). Multivariate classification analysis of metabolomic data for candidate biomarker discovery in type 2 diabetes mellitus. Metabolomics. 4(4). 337–346. 22 indexed citations

12.

Iannone, Marie A., Catherine A. Simmons, Sue H. Kadwell, et al.. (2004). Correlation betweenin VitroPeptide Binding Profiles and Cellular Activities for Estrogen Receptor-Modulating Compounds. Molecular Endocrinology. 18(5). 1064–1081. 47 indexed citations

13.

Xu, Robert X., Warren J. Rocque, Millard H. Lambert, et al.. (2004). Crystal Structures of the Catalytic Domain of Phosphodiesterase 4B Complexed with AMP, 8-Br-AMP, and Rolipram. Journal of Molecular Biology. 337(2). 355–365. 92 indexed citations

14.

Zhang, Yuemei, Stuart Cockerill, Stephen B. Guntrip, et al.. (2003). Synthesis and SAR of potent EGFR/erbB2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 111–114. 37 indexed citations

15.

Vanderwall, Dana E., et al.. (2001). Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1545(1-2). 67–77. 66 indexed citations

16.

Xu, Robert X., Anne M. Hassell, Dana E. Vanderwall, et al.. (2000). Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and Specificity. Science. 288(5472). 1822–1825. 273 indexed citations

17.

Toney, Jeffrey H., Gail G. Hammond, Xiling Yuan, et al.. (1999). Structure-activity relationships of biphenyl tetrazoles as metallo-β-lactamase inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(18). 2741–2746. 42 indexed citations

18.

Toney, Jeffrey H., Paula M.D. Fitzgerald, Steven H. Olson, et al.. (1998). Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase. Chemistry & Biology. 5(4). 185–196. 206 indexed citations

19.

Wu, Wei, Dana E. Vanderwall, Siu Man Lui, et al.. (1998). NMR Studies of Co·Deglycobleomycin A2 Green and Its Complex with d(CCAGGCCTGG). Journal of the American Chemical Society. 120(10). 2239–2250. 35 indexed citations

20.

Vanderwall, Dana E., Siu Man Lui, Wei Wu, et al.. (1997). A model of the structure of HOO-Co·bleomycin bound to d(CCAGTACTGG): recognition at the d(GpT) site and implications for double-stranded DNA cleavage. Chemistry & Biology. 4(5). 373–387. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact